Two Sigma Investments
CORV

Two Sigma Investments’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Two Sigma Investments’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,430
Closed -$5K – 4261
2019
Q4 		$5K Buy
+11,430
New +$19K ﹤0.01% 3595
2019
Q2 		– Sell
-34,784
Closed -$110K – 4002
2019
Q1 		$110K Buy
+34,784
New +$113K ﹤0.01% 2890
2018
Q4 		– Sell
-20,823
Closed -$84K – 3877
2018
Q3 		$84K Buy
+20,823
New +$91.8K ﹤0.01% 3088
2014
Q3 		– Sell
-19,104
Closed -$150K – 2189
2014
Q2 		$150K Buy
+19,104
New +$144K ﹤0.01% 2016

Other funds holding CORV

BCM
Beryl Capital Management Redondo Beach, California $109M AUM 317.92% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return